MANUFACTURERS LIFE INSURANCE COMPANY, THE - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$1,653,196
+21.6%
24,276
-42.7%
0.00%0.0%
Q2 2022$1,359,859
+0.0%
42,386
+8.4%
0.00%0.0%
Q1 2022$1,359,214
+47.4%
39,118
+24.9%
0.00%0.0%
Q4 2021$922,000
+14.5%
31,320
-0.9%
0.00%0.0%
Q3 2021$805,000
-32.2%
31,603
-6.8%
0.00%0.0%
Q2 2021$1,187,000
-36.6%
33,905
-7.5%
0.00%
-50.0%
Q1 2020$1,872,000
-32.0%
36,651
+5.8%
0.00%
-33.3%
Q4 2019$2,753,000
+58.3%
34,634
-1.9%
0.00%
+50.0%
Q3 2019$1,739,000
-1.4%
35,291
+5.3%
0.00%0.0%
Q2 2019$1,763,000
-3.8%
33,517
-3.2%
0.00%0.0%
Q1 2019$1,833,000
+45.1%
34,635
+12.5%
0.00%0.0%
Q4 2018$1,263,000
+2.8%
30,774
-4.9%
0.00%
+100.0%
Q3 2018$1,229,000
-26.4%
32,350
-12.5%
0.00%
-50.0%
Q2 2018$1,669,000
+19.0%
36,953
+27.2%
0.00%0.0%
Q1 2018$1,403,000
+25.0%
29,057
+1.9%
0.00%
+100.0%
Q4 2017$1,122,000
+27.4%
28,507
+0.4%
0.00%0.0%
Q3 2017$881,000
+11.2%
28,380
-2.1%
0.00%0.0%
Q2 2017$792,000
+48.6%
28,978
+100.3%
0.00%0.0%
Q1 2017$533,000
+183.5%
14,469
+11.1%
0.00%
Q4 2016$188,000
-31.9%
13,018
+8.7%
0.00%
Q3 2016$276,000
+58.6%
11,971
+14.2%
0.00%
Q2 2016$174,000
+128.9%
10,486
+105.8%
0.00%
Q1 2016$76,000
+94.9%
5,096
+327.5%
0.00%
Q4 2015$39,0001,1920.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders